Literature DB >> 16651745

Antimalarial activity of cassane- and norcassane-type diterpenes from Caesalpinia crista and their structure-activity relationship.

Surya Kant Kalauni1, Suresh Awale, Yasuhiro Tezuka, Arjun Hari Banskota, Thein Zaw Linn, Puji Budi Setia Asih, Din Syafruddin, Shigetoshi Kadota.   

Abstract

Malaria is one of the most life-threatening infectious diseases worldwide and claims millions of people's lives each year. The appearance of drug-resistance Plasmodium falciparum has made the treatment of malaria increasingly problematic, and thus, it is a dire need to search the new alternatives of current drugs. In the present study, 44 cassane- and norcassane-type diterpenes isolated from Caesalpinia crista of Myanmar and Indonesia were evaluated for their antimalarial activity against the malaria parasite Plasmodium falciparum FCR-3/A2 clone in vitro. Most of the tested diterpenes displayed antimalarial activity, and norcaesalpinin E (28) showed the most potent activity with an IC50 value of 0.090 microM, more potent than the clinically used drug chloroquine (IC50, 0.29 microM). Based on the observed results, a structure-activity relationship has been established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651745     DOI: 10.1248/bpb.29.1050

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  12 in total

1.  Bioactive Compounds from Medicinal Plants in Myanmar.

Authors:  Nwet Nwet Win; Hiroyuki Morita
Journal:  Prog Chem Org Nat Prod       Date:  2021

2.  Chemical components from the twigs of Caesalpinia latisiliqua and their antiviral activity.

Authors:  Mira Oh; SeonJu Park; Jae-Hyoung Song; Hyun-Jeong Ko; Seung Hyun Kim
Journal:  J Nat Med       Date:  2019-06-26       Impact factor: 2.343

3.  Bioactive compounds from Stuhlmannia moavi from the Madagascar dry forest.

Authors:  Yixi Liu; Liva Harinantenaina; Peggy J Brodie; Jessica D Bowman; Maria B Cassera; Carla Slebodnick; Martin W Callmander; Richard Randrianaivo; Etienne Rakotobe; Vincent E Rasamison; Wendy Applequist; Chris Birkinshaw; Gwilym P Lewis; David G I Kingston
Journal:  Bioorg Med Chem       Date:  2013-11-01       Impact factor: 3.641

4.  Medicinal plants used by various tribes of bangladesh for treatment of malaria.

Authors:  Mohammed Rahmatullah; Shahadat Hossan; Afsana Khatun; Syeda Seraj; Rownak Jahan
Journal:  Malar Res Treat       Date:  2012-01-23

5.  Toxicological investigation of acute and chronic treatment with Gnidia stenophylla Gilg root extract on some blood parameters and histopathology of spleen, liver and kidney in mice.

Authors:  Tilahun Alemayehu Nigatu; Mekbeb Afework; Kelbessa Urga; Wondwossen Ergete; Eyasu Makonnen
Journal:  BMC Res Notes       Date:  2017-11-28

6.  Effect of Oral Administration of Gnidia Stenophylla Gilg Aqueous Root Extract on Food Intake and Histology of Gastrointestinal Tract in Mice.

Authors:  Tilahun Alemayehu Nigatu; Mekbeb Afework; Kelbessa Urga; Wondwossen Ergete; Tewodros Gebremariam Gebretsadik; Eyasu Makonnen
Journal:  Ethiop J Health Sci       Date:  2017-01

7.  Hepatoprotective Potential of Caesalpinia crista against Iron-Overload-Induced Liver Toxicity in Mice.

Authors:  Rhitajit Sarkar; Bibhabasu Hazra; Nripendranath Mandal
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-17       Impact factor: 2.629

8.  In vitro antimalarial activity of different extracts of Eremostachys macrophylla Montbr. & Auch.

Authors:  Solmaz Asnaashari; Fariba Heshmati Afshar; Atefeh Ebrahimi; Sedigheh Bamdad Moghadam; Abbas Delazar
Journal:  Bioimpacts       Date:  2015-08-19

9.  1-Deacet-oxy-1-oxocaesalmin.

Authors:  Juan Feng; Jian-Long Zhang; Rong-Rong Zhang; Li-Jun Ruan; Ren-Wang Jiang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-05-17

10.  In Vivo Anti-Malarial Activity of Heracleum persicum Fruit Extract, in Combination with Chloroquine against Chloroquine-Sensitive Strain of Plasmodium berghei.

Authors:  Nahideh Mazhari; Mehdi Nateghpour; Peyman Heydarian; Leila Farivar; Effat Souri; Afsaneh Motevalli Haghi
Journal:  Iran J Public Health       Date:  2018-06       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.